Position in ABBV
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$4,378,536
+$217,953 QoQ
Shares Held
17,400
-9.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.92%
of 13F equity value
Holder Rank
#1,397
of 4,153 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Tyche Wealth Partners LLC holds $18,163,637 across 7 Drug Manufacturers - General names. ABBV ranks #3 (24.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
22,399 | $5,688,674 | |
| 2 | LLY |
ELI LILLY & Co
|
4,653 | $5,580,948 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
17,400 | $4,378,536 | |
| 4 | MRK |
Merck & Co., Inc.
|
8,583 | $1,102,915 | |
| 5 | AMGN |
Amgen Inc
|
1,495 | $541,369 | |
| 6 | PFE |
Pfizer Inc
|
21,503 | $517,792 | |
| 7 | NVS |
Novartis AG
|
2,255 | $353,403 |
All Filings in ABBV
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,378,536 | 17,400 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $4,160,583 | 19,130 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $4,443,445 | 19,447 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $3,930,854 | 16,977 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $3,529,564 | 19,015 | Shares | Sole | 2025-07-23 | |
| 2025-03-31 | $3,902,310 | 18,625 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $3,939,253 | 22,168 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $3,551,875 | 17,986 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $3,079,127 | 17,952 | Shares | Sole | 2024-07-18 | |
| 2024-03-31 | $2,633,894 | 14,464 | Shares | Sole | 2024-04-23 | |
| 2023-12-31 | $2,192,205 | 14,146 | Shares | Sole | 2024-01-30 | |
| No filing history on record for this holder in this stock. | ||||||